Who We Are
Summit Management Services is committed to excellence in Meetings Management in both the domestic and international pharmaceutical arena. We specialize in creating, planning and managing professional programs designed to support corporate efforts to educate and inform specific audiences on a message or product, using press, group communication forums and exhibits as vehicles to achieve these goals.
In the New Millennium, technology is essential to build better meetings, create superior events and maintain the highest level of efficiency and professionalism for all programs. Summit Management Services utilizes these available industry technologies to ensure success, savings; and most importantly, client satisfaction.
What We Do
Summit Management Services commits to meeting objectives for its clients. We deliver an exceptional level of expertise to every project.
Our client’s objectives become our mandate. This strong, focused dedication to your project provides an often overlooked but quite valuable by-product: a tremendous savings due to eliminating the need to maintain a full-time meeting planning staff.
We know that when a business divests itself of functions that are not directly relevant to its core business, it doesn’t divest itself of the need for the function – just of the need to maintain the overhead.
How We Work
Each new project brings opportunities and challenges. We are proud of our ability to respond. We work hard, with a clear focus and a commitment to quality that is second to none.
We operate on a project-by-project basis. We visit with you and gather information about your business. Depending on your specific needs and objectives, we develop a concept, a theme, a budget and we assemble a meetings team. We detail the program elements to give you a program that meets your unique situation, and bring your message to your target audience with clarity and conviction.
Our Past and Present Clients Include:
Ajinimoto Pharmaceuticals, Andryx Laboratories, Associates of Clinical Pharmacology, Athenex, Aventis Pharmaceuticals, Inc., AT&T, Avery-Dennison, Banyu, Berlex Laboratories Inc., BellSouth Cellular, Bristol-Myers Squibb Company, BioTechnology General, Inc., Cahners Publishing, Ciba Additives, Contrafect, The Covalent Group, Cephalon, Inc., Celgene, CIBA Geigy, CIDAL, Cleveland Clinic Foundation, Contrafect, Covance, Inc., Daiichi Sankyo, Dainippon Sumitomo Pharma, Duke Clinical Research Institute, Eli Lilly, GE Capital, General Motors Corporation, GlaxoSmithKline, Ikaria, Inc., Innapharma, International Clinical Research, Intercept Pharmaceutical, Ipsen Biopharmaceuticals, Inc., J.M. Huber Minerals, Jaeger Lumber, Janssen, Johnson & Johnson, Kyowa Hakko Kirin, Lucent Technologies, Medicrea International SA, Merck & Co., Inc., Millenium Pharmaceuticals, Morphotek, Namaco Industries, The Newark Museum, NOAA-CREST, Novartis, Organon Pharmaceuticals, Owens Corning Glass, Park-Davis Phamaceuticals, Pearl Therapeutics, Pfizer, Progenics, RiFM, R.W. Johnson Pharmaceutical Research Group, Sanofi Aventis, Sandoz Pharmaceuticals, Savient Pharmaceuticals, Inc., Schering-Plough Research Institute, Sprint, Stealth BioTherapeutics, Sun Microsystems, Sunovian, Sykes Technology, Timi Study Group, The William Morris Agency, Worldwide Clinical Trials, Wyeth Laboratories, Yamanouchi Pharma America, Inc.The Summit Advantage